#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	11200	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2061	537.9	0	.	n	.	0	C1450T	SNP	1450	1450	C	1684	1684	T	619	T,C	564,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	11200	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2061	537.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1418	1418	C	650	C	608	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	20678	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3667	561.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1680	1680	A	763	A	707	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	20678	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3667	561.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2314	2314	C	607	C,T,G	562,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	20678	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3667	561.9	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2940	2940	T	591	T,C	550,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	20678	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3667	561.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2388	2388	A	592	A	557	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1132	folP	852	852	93.78	folP.l15.c30.ctg.1	1493	75.6	0	.	p	.	0	G5V	NONSYN	13	15	GGT	350	352	GTT	73;73;73	G;T;T	71;71;70	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1132	folP	852	852	93.78	folP.l15.c30.ctg.1	1493	75.6	0	.	p	.	0	E12K	NONSYN	34	36	GAA	371	373	AAA	91;89;89	A;A;A	88;86;87	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1132	folP	852	852	93.78	folP.l15.c30.ctg.1	1493	75.6	0	.	p	.	0	F31L	NONSYN	91	93	TTT	428	430	TTG	92;92;94	T;T;G	84;84;86	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1132	folP	852	852	93.78	folP.l15.c30.ctg.1	1493	75.6	0	.	p	.	0	K42Q	NONSYN	124	126	AAA	461	463	CAA	114;111;111	C;A;A	102;101;102	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1132	folP	852	852	93.78	folP.l15.c30.ctg.1	1493	75.6	0	.	p	.	0	S75P	NONSYN	223	225	TCC	560	562	CCT	132;132;131	C;C;T,C	122;124;121,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1132	folP	852	852	93.78	folP.l15.c30.ctg.1	1493	75.6	0	.	p	.	0	V87A	NONSYN	259	261	GTA	596	598	GCA	119;112;112	G;C;A,G	110;104;103,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1132	folP	852	852	93.78	folP.l15.c30.ctg.1	1493	75.6	0	.	p	.	0	V130L	NONSYN	388	390	GTC	725	727	CTC	152;152;152	C,G;T,C;C	142,1;142,1;145	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1132	folP	852	852	93.78	folP.l15.c30.ctg.1	1493	75.6	0	.	p	.	0	R135C	NONSYN	403	405	CGC	740	742	TGT	153;151;150	T,C;G;T,C	139,1;138;136,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1132	folP	852	852	93.78	folP.l15.c30.ctg.1	1493	75.6	0	.	p	.	0	T137A	NONSYN	409	411	ACG	746	748	GCG	147;148;150	G;C;G	137;135;138	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1132	folP	852	852	93.78	folP.l15.c30.ctg.1	1493	75.6	0	.	p	.	0	E151K	NONSYN	451	453	GAA	788	790	AAG	137;138;138	A;A;G	129;131;130	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1132	folP	852	852	93.78	folP.l15.c30.ctg.1	1493	75.6	0	.	p	.	0	T152N	NONSYN	454	456	ACC	791	793	AAT	138;140;139	A;A;T	131;132;132	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1132	folP	852	852	93.78	folP.l15.c30.ctg.1	1493	75.6	0	.	p	.	0	F218L	NONSYN	652	654	TTT	989	991	TTG	114;112;111	T;T;G	112;110;107	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1132	folP	852	852	93.78	folP.l15.c30.ctg.1	1493	75.6	1	SNP	p	R228S	1	R228S	NONSYN	682	684	CGT	1019	1021	AGC	102;102;101	A;G;C	99;100;98	folP.Neisseria_meningitidis_M01_240149_v1_00504:1:1:R228S:folP.228S:Resistance to sulphonamides	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1132	folP	852	852	93.78	folP.l15.c30.ctg.1	1493	75.6	0	.	p	.	0	V251L	NONSYN	751	753	GTG	1088	1090	CTG	79;79;79	C;T;G	77;74;75	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1132	folP	852	852	93.78	folP.l15.c30.ctg.1	1493	75.6	0	.	p	.	0	A253S	NONSYN	757	759	GCT	1094	1096	TCC	73;71;72	T;C;C	71;70;70	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1132	folP	852	852	93.78	folP.l15.c30.ctg.1	1493	75.6	0	.	p	.	0	A258V	NONSYN	772	774	GCG	1109	1111	GTG	79;80;80	G;T;G	73;72;72	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1132	folP	852	852	93.78	folP.l15.c30.ctg.1	1493	75.6	0	.	p	.	0	V275A	NONSYN	823	825	GTG	1160	1162	GCG	107;107;104	G;C;G	102;101;98	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	3776	gyrA	2751	2751	100.0	gyrA.l6.c30.ctg.1	3421	110.1	1	SNP	p	S91F	0	.	.	271	273	TCC	595	597	TCC	122;122;123	T;C;C	115;114;117	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	3776	gyrA	2751	2751	100.0	gyrA.l6.c30.ctg.1	3421	110.1	1	SNP	p	D95N	0	.	.	283	285	GAC	607	609	GAC	115;116;117	G;A;C	112;112;114	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	3776	gyrA	2751	2751	100.0	gyrA.l6.c30.ctg.1	3421	110.1	1	SNP	p	D95G	0	.	.	283	285	GAC	607	609	GAC	115;116;117	G;A;C	112;112;114	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	531	1294	mtrR	633	633	99.68	mtrR.l6.c30.ctg.1	1389	92.5	0	.	p	.	0	Q133trunc	TRUNC	397	397	C	761	761	T	152	T	141	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	698	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	972	71.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	3728	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2966	125.2	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1481	1483	ATC	143;143;142	A;T;C	133;136;135	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	3728	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2966	125.2	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1634	1636	GCA	147;149;148	G;C,G;A	136;136,1;134	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	3728	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2966	125.2	1	SNP	p	D86N	0	.	.	256	258	GAC	587	589	GAC	153;152;154	G;A;C	145;138;143	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	3728	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2966	125.2	1	SNP	p	S87W	0	.	.	259	261	AGT	590	592	AGT	155;156;156	A;G;T	146;145;145	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	3728	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2966	125.2	1	SNP	p	S87I	0	.	.	259	261	AGT	590	592	AGT	155;156;156	A;G;T	146;145;145	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	3728	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2966	125.2	1	SNP	p	S87R	0	.	.	259	261	AGT	590	592	AGT	155;156;156	A;G;T	146;145;145	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	3728	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2966	125.2	1	SNP	p	S88P	0	.	.	262	264	TCC	593	595	TCC	158;157;160	T;C;C	148;145;148	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3196	parE	1986	1986	99.95	parE.l6.c4.ctg.1	2573	123.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1551	1553	GGC	171;172;169	G;G;C	160;159;159	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.14.001	penA.14.001	1	1	27	3082	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2278	134.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1237	1239	GCA	189;188;188	G;C;A	174;173;175	penA.14.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3082	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2278	134.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1240	1242	ATC	189;189;191	A;T;C	177;177;179	penA.14.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3082	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2278	134.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1252	1254	GTG	181;180;182	G;T;G	172;170;169	penA.14.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3082	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2278	134.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1252	1254	GTG	181;180;182	G;T;G	172;170;169	penA.14.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3082	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2278	134.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1756	1758	ACC	142;141;142	A;C;C	128;128;132	penA.14.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3082	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2278	134.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1810	1812	GCG	131;133;132	G;C,G;G	121;107,2;114	penA.14.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3082	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2278	134.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1810	1812	GCG	131;133;132	G;C,G;G	121;107,2;114	penA.14.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3082	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2278	134.5	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1933	1935	GGT	127;128;127	G;G;T	119;120;119	penA.14.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3082	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2278	134.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1942	1944	GGC	125;126;125	G;G;C	114;114;115	penA.14.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3082	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2278	134.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1960	1962	CCG	98;98;96	C,G;C;G	77,4;80;77	penA.14.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4638	ponA	2397	2397	99.96	ponA.l15.c30.ctg.1	3200	144.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1664	porA	1146	1146	99.74	porA.l15.c4.ctg.1	1821	90.8	0	.	p	.	0	S22G	NONSYN	64	66	AGC	407	409	GGC	112;109;110	G;G,A;C	101;97,1;98	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1664	porA	1146	1146	99.74	porA.l15.c4.ctg.1	1821	90.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	589	589	C	110	C	101	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2392	porB1b	1035	1035	98.66	porB1b.l15.c4.ctg.1	1552	152.9	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	923	923	T	173	T	157	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2392	porB1b	1035	1035	98.66	porB1b.l15.c4.ctg.1	1552	152.9	1	SNP	p	G120K	0	.	.	358	360	GGT	650	652	GGT	181;183;182	G;G;T	165;169;164	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2392	porB1b	1035	1035	98.66	porB1b.l15.c4.ctg.1	1552	152.9	1	SNP	p	A121D	0	.	.	361	363	GCC	653	655	GCC	180;180;177	G;C;C	165;166;166	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2392	porB1b	1035	1035	98.66	porB1b.l15.c4.ctg.1	1552	152.9	1	SNP	p	A121N	0	.	.	361	363	GCC	653	655	GCC	180;180;177	G;C;C	165;166;166	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8554	rpoB	4179	4179	99.95	rpoB.l15.c30.ctg.1	5074	168.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	912	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	998	90.9	1	SNP	p	V57M	1	.	.	169	171	ATG	552	554	ATG	208;210;207	A;T;G	197;199;194	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
